dorsaVi Ltd (ASX: DVL) has begun testing its new RRAM-powered sensor systems, marking a significant milestone in its push toward real-time, low-power biomedical applications.
Key Highlights:

  • RRAM sensor systems delivered to Singapore for real-world testing in EMG (electromyography) and ECG (electrocardiography) use cases.
  • Hybrid RRAM–NAND setup targets speed, efficiency & durability
  • RRAM enables sub-200ns speed, ultra-low power, high endurance, and analog capability ideal for edge processing.
  • Future use cases include adaptive prosthetics, implantable devices, e-skin sensors, closed-loop systems, and more.
  • Test results expected within July, informing dorsaVi’s product roadmap and clinical deployment strategy.

Link to the Announcement: Click Here